The Venture Codex Logo

The Venture Codex

South Australian Research & Development Institute

Waite Research Precinct, Plant Research Centre, Urrbrae, SA, 5064, Australia

Overview

The South Australian Research and Development Institute (SARDI) provides research and development services to the state government, commercial clients, and research partners to help make South Australia’s primary industries and regions internationally competitive and ecologically sustainable. SARDI’s programs are designed to increase the productivity, sustainability, and adaptability of the state’s agriculture, food and wine, fisheries and aquaculture, and bioscience enterprises, create opportunities for market growth, address barriers to growth and provide applied solutions.

Total investments
1
Lead investments
0
Investments · 12mo
0
Active investors
0
Visit website

Investment portfolio

  • CH4 Global

    Participated · Seed · Sep 2020

    CH4 Global produces Methane Tamer™, a feed additive made from whole, dried Asparagopsis seaweed designed to reduce methane emissions in cattle by up to 90%. The company states its approach can deliver gigaton-scale emissions reductions over the next decade. CH4 Global is based in Henderson, NV. It received an investment from Chipotle Mexican Grill; the amount of the deal was not disclosed. The company intends to use the funds to scale production of Methane Tamer to meet global demand for natural solutions to mitigate methane emissions. The article does not disclose any revenue, user metrics, past funding rounds, or additional financial details. CH4 Global develops feed additives for the food-industry value chain to reduce greenhouse-gas emissions; its signature product, Methane Tamer, harnesses Asparagopsis seaweed to cut enteric methane by as much as 90%. Led by CEO Steve Meller and based in Henderson, NV, the company says it is seeing strong interest from governments, food producers and farmers. CH4 Global operates subsidiaries in Australia and New Zealand. The company plans to use new funding to build and validate the CH4 Global EcoPark™, an aquaculture and production facility to grow and process Asparagopsis and manufacture Methane Tamer at scale. Management frames the EcoPark as a low-cost growth and processing solution designed to accelerate commercial availability and meet emerging regulatory and market demand. The article does not disclose revenue or user metrics. CH4 Global develops and commercializes Asparagopsis red seaweed feed supplements that can reduce cattle methane emissions by up to 90% and improve feed conversion. The company has built hatchery, aquaculture, processing and formulation capabilities to produce its feed products. Founded in 2019, CH4 Global operates offices in the U.S., Australia and New Zealand and is a Delaware corporation based in Henderson, Nevada. It plans to use the Series A proceeds to establish a research and production facility in Adelaide, South Australia, and to bring its first commercial product to market in 2022. The company will also focus on supply-chain optimization to develop reliable, repeatable manufacturing capabilities to scale production in 2023 and beyond. CH4 Global centers farmers in its commercialization strategy and targets feedlots, dairies, and remote cattle operations while positioning its work as urgent for climate impact given methane's near-term warming effect. CH4 Global scales the aquaculture and processing of Asparagopsis armata to produce a livestock supplement that can reduce methane emissions from ruminants by up to 90%. The company closed a $3M seed round from family offices and private investors and has received non-dilutive capital from government innovation groups including the New Zealand Provisional Growth Fund, South Australian Research & Development Institute, Australian Fisheries Research Development Corporation, and the South Australian Landing Pad. Founded 18 months ago by an international team of senior scientists, technology entrepreneurs, and business executives from Australia, New Zealand, and the US, CH4 Global is headquartered in San Francisco as a Delaware corporation. Its initial market focus is dairy and beef cattle in Australia, New Zealand, and California, a market the company says could exceed $10 billion by 2030. CH4 is actively acquiring and partnering for commercial aquaculture space in South Australia and New Zealand and formalizing customer relationships to get product to market quickly. The company leverages validated research from CSIRO, Meat & Livestock Australia, James Cook University and recent validations from UC Davis and Penn State to commercialize Asparagopsis-based supplements and aims to become the leading global supplier.

Team

No current team members are available.